ADA and metabolic dysfunction-associated steatotic liver disease: While our results demonstrate lower levels of total ADA in NASH-patients compared to NAFL, probably highlighting important roles besides its role in fibrosis development, this emphasizes ADA as an interesting molecule for NAFLD development and emphasizes the need of future studies to fully elucidate its role.